We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ferromagnetic Nanoparticles Used in New Immunoassays

By HospiMedica staff writers
Posted on 22 Oct 2007
Immunoassays have been developed based on the peroxidase activity of ferric oxide (Fe3O4) magnetic nanoparticles (MNPs).

The nanoparticles are active catalysts, and the catalytic activity is greater in smaller particles. More...
In addition, iron oxide nanoparticles are more stable over a variety of temperatures and varying levels of acidity, giving them an additional advantage over the traditional horseradish peroxidase that is used in the enzyme-linked immunosorbant assay (ELISA).

Most immunoassays are ELISAs. Because it can evaluate the presence of an antigen or antibody in a sample, the ELISA is commonly used to test for human immunodeficiency virus (HIV), hepatitis B, and West Nile Virus. The test basically involves an antigen attached to a solid surface. When the antibody is washed over the surface, it binds to the antigen. The antibody is then linked to an enzyme, usually a peroxidase, which reacts with certain substrates, resulting in a change in color. The evolution of immunoassays has continued with developments such as the fluorimetric immunoassay.

Prof. Xiyun Yan from the National Laboratory of Biomacromolecules in the Institute of Biophysics of the Chinese Academy of Sciences (CAS; Beijing, PR China), and colleagues showed that iron oxide nanoparticles are intrinsically active catalysts for oxidation reactions.

"The magnetic properties allow separation of the target from a complex solution, and the peroxidase assay can then be used to detect and quantify the amount of the target molecule,” said Prof. Yan. According to the CAS scientists, magnetic ELISA assays are already widely used for laboratory and diagnostic purposes. However, the difference when using the intrinsic activity of the MNPs compared to the traditional ELISA, is that there is no need for the binding step with a secondary, enzyme-counjugated antibody.

Prof. Yan and her collaborators have already developed two novel immunoassays (one for hepatitis B and the other for myocardial infarction) that exploit this new discovery. Using the appropriate antibody, the nanoparticles capture the target molecule in solution and then a magnet is used to isolate the nanoparticles. With the simple addition of a peroxidase-sensitive dye, the solution changes from clear to blue in the presence of the nanoparticles.

According to the scientists, the stability, ease of production, and versatility of the iron oxide nanoparticles makes them a powerful tool for a wide range of potential applications in clinical diagnostics, biotechnology, and environmental chemistry.

"The MNP assay would be worth developing commercially, because it is cheaper, faster, more direct, and potentially more sensitive,” said Prof. Yan. "… we are already collaborating with a company to develop the MNP-based immunoassay and to apply MNPs for the treatment of wastewater. The magnetic properties allow separation of the target from a complex solution and the peroxidase assay can then be used to detect and quantify the amount of the target molecule.”

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.